Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00729430 · ClinicalTrials.gov registry record · Phase 3
Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging
A Phase 3 study of Myocardial Infarction and Death, Sudden, Cardiac, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 358
- Enrollment target
- 1
- Study location
NCT00729430: Completed Phase 3 study of Myocardial Infarction and Death, Sudden, Cardiac, sponsored by Brigham and Women's Hospital.
NCT00729430 is a Phase 3 study of Myocardial Infarction and Death, Sudden, Cardiac that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 358 participants, below the 4,676-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00729430, a Phase 3 study of Myocardial Infarction and Death, Sudden, Cardiac, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 358 participants
- Enrollment target
- 1
- Study location
Study Summary
Doctors use magnetic resonance imaging (MRI) to obtain detailed pictures of the inside of the body. This study will evaluate a new MRI technique in people who have recently had a heart attack. Researchers will also examine the effect of fish oil supplementation on heart health in study participants.
Primary Outcome
Measured as change in left ventricular end-systolic volume indexed to body surface area from baseline to post-treatment (6-months)
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Omega-3 Fatty Acids (Fish Oil Supplements)
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital, Shapiro Cardiovascular Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 358 participants |
| Start Date | 2008-08 |
| Est. Completion | 2014-07 |
| Phase | Phase 3 |
What the finished NCT00729430 record still lists
NCT00729430 is an interventional study that assigns participants to a tested intervention. The registered 358 participants enrollment target is mid-sized for trials with a published cap, below the 4,676-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Myocardial Infarction appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00729430 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00729430 about?
NCT00729430 is a clinical study titled "Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging". Doctors use magnetic resonance imaging (MRI) to obtain detailed pictures of the inside of the body. This study will evaluate a new MRI technique in people who have recently had a heart attack. Researchers will also examine the effect of fish oil supplementation on heart health in study participants.
What is the current status of trial NCT00729430?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 358 participants. The study started on 2008-08. Estimated completion is 2014-07.
What conditions does trial NCT00729430 study?
This clinical trial studies the following conditions: Myocardial Infarction, Death, Sudden, Cardiac.
What interventions are being tested in trial NCT00729430?
The interventions under investigation include: Placebo (DRUG), Omega-3 Fatty Acids (Fish Oil Supplements) (DRUG).
Who is sponsoring clinical trial NCT00729430?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00729430 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00729430's enrollment target sits among peer trials
358 34th of 64 higher than 31 of 64 other Myocardial Infarction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myocardial Infarction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
COMPLETED · Phase 3
-
Occluded Artery Trial (OAT)
COMPLETED · Phase 3
-
IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.
COMPLETED · Phase 3
-
An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
COMPLETED · Phase 3
-
Myocardial Ischemia and Transfusion Pilot
COMPLETED · Phase 3
-
Vitamin Therapy for Prevention of Stroke
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04373317 · 358 participants · Phase 4
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
- NCT05684965 · 358 participants · Phase 1
XTX301 in Patients With Advanced Solid Tumors
- NCT05824975 · 358 participants · Phase 1
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- NCT06480227 · 358 participants · NA
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia